Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Day One Biopharmaceuticals (DAWN) Gross Margin: 2024-2025

Historic Gross Margin for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Sep 2025 value amounting to 100.00%.

  • Day One Biopharmaceuticals' Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is N/A change from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Gross Margin stood at 100.00% for Q3 2025, which was down 0.00% from 100.00% recorded in Q2 2025.
  • Day One Biopharmaceuticals' 5-year Gross Margin high stood at 100.00% for Q2 2024, and its period low was 100.00% during Q2 2024.
  • Over the past 2 years, Day One Biopharmaceuticals' median Gross Margin value was 100.00% (recorded in 2025), while the average stood at 100.00%.